Transfection reagent

Monday, 06 August, 2007 | Supplied by: Life Technologies



Lipofectamine LTX Reagent offers a solution for gene expression as it is a plasmid DNA-specific transfection reagent that can provide the same level of reproducible and efficient gene expression in a wide range of cell lines, including primary and disease-related cells. Lipofectamine LTX Reagent is synthesised from 100% animal origin-free components, making it easy to validate the absence of zoonotic diseases, such as BSE or viruses, in experiments or cell lines. A certificate of origin may be obtained.

Lipofectamine LTX Reagent offers: easy optimisation and minimal cytotoxicity; high gene expression; compatibility with a broad range of cell types; and a simple one-tube protocol.

The reagent delivers both high levels of protein expression and lower cytotoxicity in a wide range of cell types. Cell line-specific protocols enable users to optimise any gene expression experiment.

Achieving high levels of target protein expression enables cells to respond to assay conditions, which helps users to obtain relevant data from functional genomics expression studies.

With the ability to transfect a broad range of cell types, including primary and disease-related cells, Lipofectamine LTX Reagent provides a versatile approach for all transient and stable gene expression experiments. Recommended transfection conditions for these cell types are available.

Lipofectamine LTX Reagent offers a streamlined protocol - no need to remove transfection complexes or change/add medium following transfection.

Online: www.invitrogen.com
Phone: 1800 331 627
Related Products

BioActs Fluorescent FSD Fluor Dyes

The FSD Fluor series is a panel of fluorescent dyes with good fluorescence intensity and a high...

Ansell BioClean PPE range

BioClean products are part of Ansell Limited's Life Sciences Solutions portfolio, offering a...

Larodan research-grade glycerides

Larodan develops a comprehensive range of research-grade lipids for use as analytical standards...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd